Current Topics in Allergy/Immunology 2026: Novel High-Impact Tools in Allergy/Immunology

Friday, October 30, 2026, 7:30 AM - 4:00 PM, Hyatt Regency Coralville, Coralville, IA

This conference provides updates on emerging therapies and clinical advances in allergy and immunology. Topics include novel treatments for atopic dermatitis, oral immunotherapy, biologics in allergen immunotherapy, JAK inhibitors, STAT gain-of-function disorders, alpha-gal allergy, PFAPA, and the impact of GLP-1 agonists on allergic disease. Participants will gain practical, evidence-based insights to improve the diagnosis and management of patients with allergic and immunologic conditions.

AMA PRA Category 1 Credits™ (6.25 hours), AAPA Category 1 CME credit (6.25 hours), ACPE Credit (6.25 hours), ANCC Contact Hours (6.25 hours), Non-Physician Attendance (6.25 hours)

1. Describe the importance of the JAK-STAT pathway in allergy/immunology
2. Explain Alpha-gal allergy and its management
3. Compare and contrast different new therapies for atopic dermatitis
4. Appraise the evidence for oral allergen immunotherapy in food allergy
5. Examine the use of biologics in the setting of allergen immunotherapy
6. Critique GLP1 agonist date in allergy/immunology
7. Implement the use of JAK inhibitors in hyperinflammation
8. Discuss the use of tonsillectomy for Periodic Fever, Aphthous stomatitis, Pharyngitis, Adenitis syndrome
9. Collaborate as a healthcare team to discuss complex allergy/immunology cases and apply evidence-based approaches to patient care

Physician $200
Pharmacist/Advanced Practice Provider (PA/NP) $130
Other Health Professional $110
Retiree $100
UI Faculty and Staff* $0
Resident/Student $0
Industry Rep attending as learner $200

*You must have a HawkID to receive the UI affiliated rate.

Cancellation Policy
All but $25 of the fee is refundable if inability to attend is made known on or before October 21, 2026. Refunds will not be made after this date.

In support of improving patient care, the University of Iowa Roy J. and Lucille A. Carver College of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this Live Activity for a maximum of 6.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Pharmacist: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this knowledge-based activity for a maximum of 6.25 ACPE contact hours. Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must provide their NABP ID and DOB (MMDD) to receive credit.   JA0000310-0000-26-055-L01-P

Physician Associate: The University of Iowa Roy J. and Lucille A. Carver College of Medicine has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 6.25 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 6.25 ANCC contact hours.

Other Health Care Provider: A certificate of participation will be available after successful completion of an online evaluation. It is the responsibility of the licensees to determine if this continuing education activity meets the requirements of their professional licensure board.

DISCLOSURE POLICY: Everyone in a position to control the content of this educational activity will disclose to the accredited provider all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships will be mitigated.

Mitigation of Relevant Financial Relationships

University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.